NCT04181476View on ClinicalTrials.gov

Efficacy Evaluation of Products Against Long Wavelength Ultraviolet A1 and Visible Light Induced Biological Effects

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 5, 2019

Primary Completion Date

January 18, 2021

Study Completion Date

June 30, 2022

Conditions
Sun Damaged Skin
Interventions
DRUG

Sunscreening Agents

Four different sunscreens

Trial Locations (1)

48202

Department of Dermatology, Henry Ford Medical Center, 3031 West Grand Boulevard,, Detroit

All Listed Sponsors
collaborator

L'Oreal

INDUSTRY

lead

Henry Ford Health System

OTHER